Bright Minds Biosciences (XCNQ:DRUG) Short-Term Capital Lease Obligation : C$0.06 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bright Minds Biosciences Short-Term Capital Lease Obligation?

Bright Minds Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.06 Mil.

Bright Minds Biosciences's quarterly Short-Term Capital Lease Obligation declined from Jun. 2023 (C$0.08 Mil) to Sep. 2023 (C$0.07 Mil) and declined from Sep. 2023 (C$0.07 Mil) to Dec. 2023 (C$0.06 Mil).

Bright Minds Biosciences's annual Short-Term Capital Lease Obligation increased from Sep. 2021 (C$0.00 Mil) to Sep. 2022 (C$0.07 Mil) and increased from Sep. 2022 (C$0.07 Mil) to Sep. 2023 (C$0.07 Mil).

Bright Minds Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Bright Minds Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Minds Biosciences Short-Term Capital Lease Obligation Chart

Bright Minds Biosciences Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Short-Term Capital Lease Obligation

0.07

Bright Minds Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial												0.07	0.07	0.08	0.07	0.06

Bright Minds Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Bright Minds Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bright Minds Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Minds Biosciences (XCNQ:DRUG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bright Minds Biosciences Inc (XCNQ:DRUG) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

DRUG:USA

Address

19 Vestry Street, New York, NY, USA, 10013

Website

https://www.brightmindsbio.com

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.